EUVIMEDEUVIMED entdecken
Open Access

d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma

Shulan Han iD, Xueying Bao iD, Yifang Zou iD, Lingzhi Wang iD, Yutong Li, Leilei Yang, Anqi Liao, Xuemei Zhang, Xin Jiang, Di Liang, Yun Dai iD, Qing-Chuan Zheng iD und 2 weitere

Science Advances · 21.07.2023 · 9 (29)

DOI: 10.1126/sciadv.adg2697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 21.07.2023. Verfasst von Shulan Han und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 326-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The polarization of tumor-associated macrophages (TAMs) from M2 to M1 phenotype demonstrates great potential for remodeling the immunosuppressive tumor microenvironment (TME) of hepatocellular carcinoma (HCC). d -lactate (DL; a gut microbiome metabolite) acts as an endogenous immunomodulatory agent that enhances Kupffer cells for clearance of pathogens. In this study, the potential of DL for transformation of M2 TAMs to M1 was confirmed, and the mechanisms underlying such polarization were mainly due to the modulation of phosphatidylinositol 3-kinase/protein kinase B pathway. A poly(lactide- co -glycolide) nanoparticle (NP) was used to load DL, and the DL-loaded NP was modified with HCC membrane and M2 macrophage-binding peptide (M2pep), forming a nanoformulation (DL@NP-M-M2pep). DL@NP-M-M2pep transformed M2 TAMs to M1 and remodeled the immunosuppressive TME in HCC mice, promoting the efficacy of anti-CD47 antibody for long-term animal survival. These findings reveal a potential TAM modulatory function of DL and provide a combinatorial strategy for HCC immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMiceAnimalsTumor-Associated MacrophagesLactic AcidTumor MicroenvironmentImmunosuppressive AgentsCell Line, Tumor

Substanzen

Lactic AcidImmunosuppressive Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
  • Department of Radiation Oncology, The First Hospital of Jilin University, Changchun 130021, China.
  • Department of Hepatopathy, Shuguang Hospital, affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Laboratory of Cancer Precision Medicine, The First Hospital of Jilin University, Changchun 130021, China.
  • Institute of Theoretical Chemistry, College of Chemistry, Jilin University, Changchun 130023, China.
  • Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, Jilin University, Changchun 130012, China.

ORCID-Profile: Shulan Han, Xueying Bao, Yifang Zou, Lingzhi Wang, Yun Dai, Qing-Chuan Zheng, Zhuo Yu, Jianfeng Guo

Zitieren

APA

Han, S., Bao, X., Zou, Y., Wang, L., Li, Y., Yang, L., Liao, A., Zhang, X., Jiang, X., Liang, D., Dai, Y., Zheng, Q. C., Yu, Z., & Guo, J. (2023). d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Science Advances, 9(29). https://doi.org/10.1126/sciadv.adg2697

Vancouver

Han S, Bao X, Zou Y, Wang L, Li Y, Yang L, et al. d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Science Advances. 2023;9(29). doi:10.1126/sciadv.adg2697

BibTeX
@article{Han2023,
  author = {Han, Shulan and Bao, Xueying and Zou, Yifang and Wang, Lingzhi and Li, Yutong and Yang, Leilei and Liao, Anqi and Zhang, Xuemei and Jiang, Xin and Liang, Di and Dai, Yun and Zheng, Qing-Chuan and Yu, Zhuo and Guo, Jianfeng},
  title = {d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {29},
  doi = {10.1126/sciadv.adg2697}
}
Kostenlos starten →